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We evaluate the sedative and hypnotic activities of the methanolic and aqueous extract of Lavandula oﬃcinalis L. on central
nervous system (CNS). In this study, the eﬀect of the methanolic and aqueous extracts of this plant was investigated in a battery
of behavioural models in mice. Stems and ﬂowers of Lavandula oﬃcinalis L. have several therapeutic applications in folk medicine
in curing or managing a wide range of diseases, including insomnia. The methanolic extract produced signiﬁcant sedative eﬀect at
the doses of 200, 400, and 600mg/kg (by oral route), compared to reference substance diazepam (DZP), and an hypnotic eﬀect at
the doses of 800 and 1000mg/kg while the treatment of mice with the aqueous extract at the doses of 200 and 400mg/kg via oral
pathway signiﬁcantly reduced in both the reestablishment time and number of head dips during the traction and hole-board tests.
In conclusion, these results suggest that the methanolic and aqueous extracts of Lavandula oﬃcinalis possess potent sedative and
hypnotic activities, which supported its therapeutic use for insomnia.
1.Introduction
Morocco is fortunate to have such varied climate that almost
any medicinal plant can grow. The varied climate and
heterogeneous ecologic condition in Morocco have favoured
the proliferation of more than 42,000 species of plants,
divided into 150 families and 940 genuses [1–3]. Insomnia
deﬁned as persistent diﬃculty in falling or staying a sleep
that aﬀects function can induce signiﬁcant psychological
and physical disorder. Sedatives are drugs that decrease
activity and have a calming, relaxing eﬀect. At higher doses,
sedatives usually cause sleep. Drugs used mainly to cause
sleep are called hypnotics. The diﬀerence between sedatives
and hypnotics, then, is usually the amount of the dose;
lower doses have a calming eﬀect and higher doses cause
sleep [4]. Recent studies have shown that herbal drugs
exert good sedative and hypnotic eﬀect on the central
nervous system [4–6]. In recent years, Lavandula oﬃcinalis
ﬂowers exhibit such various biological and pharmacological
activities as anti-tumour, anti-inﬂammatory, antihistaminic,
antidiabetic, and antimicrobial activity and modulating
the central nervous system [2, 7–11]. The aim of this
experiment is to evaluate the sedative and hypnotic activities
of Lavandula oﬃcinalis methanolic and aqueous extract, and
to, therefore, determine the scientiﬁc basis for its use in
traditional medicine in the management of central nervous
system disorders.
2.MaterialsandMethods
2.1. Plant Material. Stems and ﬂowers of Lavandula
oﬃcinalis L. were collected based on ethnopharmacological
information from the villages around the region Rabat-Sale-
Zemour-Zaers, with the agreement from the authorities and2 Advances in Pharmacological Sciences
respecting the United Nations Convention of Biodiversity
and with assistance of traditional medical practitioner. The
plant was identiﬁed with botanist of scientiﬁc institute (Pr.
M. Ibn Tatou). A voucher specimen (N◦256) was deposited
in the Herbarium of Botany Department of the Scientiﬁc
Institute of Rabat.
2.2. Preparation of Extract. Stems and ﬂowers of Lavandula
oﬃcinalis were successively extracted with methanol by
maceration at room temperature (25◦C) over period of 48
hours. 500g of plant material and one litre of methanol
were used in the extraction. Methanol containing the extract
was then ﬁltered through Whatman paper and the solvent
was vacuum distilled at 65◦C in a rotary evaporator. The
remaining extract was ﬁnally dried in the oven at 30◦Cf o r
two hours to ensure the removal of any residual solvent
(lyophilisation). Final extract was a dark green powder in
percentage dry weight 21.8%. For the aqueous extract, 500g
of plant material was extracted by infusion boiled water
(500mL) for three days. The respective aqueous extracts
were separated from its residues by gravity ﬁltration. The
ﬁnal crude extract was obtained as yellow greasy powder in
percentagefromdryweight(15.7%d.w).Theseextractswere
kept in deep freeze at −20◦C until use.
2.3. Animals. Male Swiss mice (20–25g) (Iﬀa-credo, France)
were used in pharmacological tests and females of the same
strain in the LD50 calculation. The animals were fed ad
libitum with standard food and water except when fasting
was required in the course of the study. The animals
were acquired from the animal experimental centre of
Mohammed V Souissi University, Medicine and Pharmacy
Faculty, Rabat.
2.4. Acute Toxicity. Median lethal dose (LD50)v a l u e sw e r e
determined as described by Litchﬁeld and Wilcoxon [12].
S e v e ng r o u p so fm i c eo fb o t hs e x e s( n = 10, 5 males and 5
females) received or not single oral doses at diﬀerent con-
centrations (500, 1000, 1500, 2000, 3000, and 5000mg/kg,
p.o.). The control group received only the water or saline
solution.Afterasingledoseadministration,micewereplaced
in individual clear plastic boxes and continuously observed
for 6h and at 24h time interval to detect any eventual
side eﬀects. The number of animals, which died during this
period, was expressed as percentile. The LD50 of the extract
wereestimatedbythep.o.routeusingtheprocedurereported
by Litchﬁeld and Wilcoxon; the method estimated the dose
of the extract that would kill 50% of a reduced sample of
animals by a given route. In a ﬁrst phase, the extract was
given to ten mice per group at doses of 500 and 1000mg/kg;
when no mortality was observed, the doses were increased
to 1500, 2000, 3000, and 5000mg/kg. Mice were kept under
observation for 14 days to register possible mortality, their
weights were registered, and at the end of the study they
were sacriﬁced for macroscopic tissue examination [13], and
the LD50 was determined by probit test using death percent
versus doses log [14–16]. Of note, drugs used as control were
given to mice in similar conditions.
2.5. Drugs. A l ld r u g sa n de x t r a c t sw e r ef r e s h l yp r e p a r e do n
the day of the experiments. A control group received distilled
water (10mL/kg, p.o.) as vehicle. Diazepam (3mg/kg, i.p.,
a conventional sedative) and thiopental (60mg/kg, i.p., a
conventional hypnosis) were used as positive control.
2.6. Pharmacological Evaluations. The activity of methanolic
and aqueous extract from Lavandula oﬃcinalis on the
central nervous system was then studied, using a battery of
behavioral tests used in psychopharmacology. We analyzed
the eﬀect of diﬀerent doses of the methanolic extracts (100,
200, 400, and 600mg/kg, p.o.) and aqueous extracts (100,
200, and400mg/kg, p.o.) fromLavandulaoﬃcinalis fortheir
sedative and hypnotic activities. For testing sedative eﬀect,
the eﬀect of extract on mice was qualiﬁed in one of the
following tests.
2.7. Traction Test. Mice were individually suspended by
anterior limbs to a wire stretched horizontally. Abnormal
mice that fail to make a reestablishment at least one of
its posterior limbs to reach the wire are considered as
subject under a sedative action. When the animals perform
normal reestablishment immediately, the reaction is known
as positive; other wise, the reaction is called negative; also,
the behaviours of animals were recorded during the period
of the experiment [17, 18].
2.8. Fireplace Test. The apparatus used for this test consist of
a vertical glass tube 30cm in length. Mice were individually
placed vertically in the glass test tube, a normal mouse
typically attempts to escape in thirty seconds, and the mice
considered as subject to the sedative eﬀect when performing
the rise of cylinder greater than 30sec [19].
2.9. Hole-Board Test. Mice were individually placed in the
centre of a perforated board, and the number of head dips
was registered during a 5min. The perforated board test was
made by using a wood ﬂoor board, 40cm × 40cm × 25cm,
in which evenly spaced holes were made. The number of
explored holes provide a measure of the number of head dips
[20, 21].
2.10. Thiopental-Induced Sleep in Mice. Thiopental (a sub-
hypnotic dose) 60mg/kg was injected i.p. 30min after
administration of methanolic and aqueous extracts. The
mice were treated with diﬀerent doses of methanolic and
aqueous extracts (800, 1000mg/kg, p.o., n = 5), the
control group (n = 5) was treated with distilled water
(10mL/kg, p.o.), and positive control group (n = 5) was
administrated with diazepam (3mg/kg, i.p.), respectively.
The eﬀect was recorded for disappearance (latency) and
reappearance (duration) of the righting reﬂex. Hypnotic
sleeping time was considered to be the time interval between
disappearanceandreappearanceoftherightingreﬂex[5,22].
2.11. Statistical Analysis. The statistical analysis was done
using ANOVA. The results with P<0.05 were considered
signiﬁcant. The data are expressed as mean ± SD.Advances in Pharmacological Sciences 3
3. Results
3.1. Acute Toxicity of Lavandula oﬃcinalis Methanolic and
Aqueous Extracts. Following oral administration of Lavan-
dula oﬃcinalis extract at the doses of 500, 1000, 1500, 2000,
3000, and 5000mg/kg, p.o., no toxicity and no signiﬁcant
changes in the body weight between the control and treated
groupweredemonstratedatthesedoses.Thisresultindicates
that, the LD50 was higher than 5000mg/kg.
3.2. Sedative Activity of the Methanolic and Aqueous Extract
on the Central Nervous System (CNS). The results of psy-
chotropic eﬀects of methanolic and aqueous extracts were
expressedbycomparisonwithcontrolgroups.Pharmacolog-
ical tests were then performed at nontoxic doses (i.e., 100,
200, 400, and 600mg/kg, p.o.), for the methanolic extract
and (100, 200, and 400mg/kg, p.o.), for the aqueous extract.
3.3. Traction Test. The methanolic extract of Lavandula
oﬃcinalis given by oral route at 100mg/kg did not signiﬁ-
cantly alter the reestablishment time; all animals performed
normal reestablishment immediately (P>0.05). However,
the extract at the dose of 200mg/kg produced signiﬁcant
sedative eﬀect on the central nervous system (CNS) as
indicated by the relatively high time for the reestablishment
of the mice (Table 1). By increasing the doses to 400 and
600mg/kg, the average reestablishment time was increased.
The reestablishment time was notably higher than control
group (P<0.001) (Table 1). For the aqueous extract, after
oral administration at the dose of 100mg/kg, all animals
performed normal reestablishment time (notably decreased
the reestablishment time). This indicates that this extract
produced no signiﬁcant sedative eﬀect on mice behavior at
this dose (P>0.05) (Table 2). By increasing the doses to 200
and 400mg/kg, the reestablishment time was increased; the
mice fail to make a reestablishment immediately (P<0.001).
So, the aqueous extract of Lavandula oﬃcinalis produced
signiﬁcant sedative eﬀect at the doses of 200 and 400mg/kg
p.o. (Table 2). In addition, the dose of 100mg/kg of both
extracts did not decreased the reestablishment time.
3.4. Fireplace Test. Animal treated with the methanolic
extract of Lavandula oﬃcinalis at the dose of 100mg/kg via
oral route do not show loss of initiative and curiosity. By
increasing the doses to 200, 400, and 600mg/kg, all mice
lose initiative and curiosity; that is, animal did not attempt
to mount the tube for escape (P<0.01) (Table 1). While,
the aqueous extract, at the doses of 100mg/kg, produced
no sedative eﬀect, at the doses of 200 and 400mg/kg p.o.,
all animals treated showed loss of initiative and curiosity
(P<0.001) (Table 2).
3.5. Hole-Board Test. In the hole-board test, a signiﬁcant
reduction in the number of head dips at the doses of 200,
400, and 600mg/kg by oral route administration; with the
exception at the dose of 100mg/kg, the methanolic extract
did not reduce the number of head dips. However, animal
treatedwiththeaqueousextractatthedosesof100mg/kgdid
notreducethenumberofheaddips(P>0.05).Byincreasing
the doses to 200 and 400mg/kg, this extract reduced the
cumulative number of holes explored and the number of
spaces between two holes explored (en relation with motor
activity)(P<0.001)(Table 1).Thedataleadtoconcludethat
the methanolic and aqueous extract of Lavandula oﬃcinalis
possess potential sedative eﬀects on the central nervous
system at the doses of 200, 400, and 600mg/kg via oral route
administration (Tables 1 and 2).
3.6. Thiopental-Induced Sleep in Mice. We observed that the
lavender methanolic extract (ME) had induced hypnotic
eﬀectsigniﬁcant(P<0.001).Hypnosisinducedbymethano-
lic extract (800 and 1000mg/kg, p.o.) was evaluated by
observation of the duration of thiopental-induced sleeping
time. The extract showed a reduction in the time of onset
of sleep induced by thiopental. The eﬀects of the extract on
onset of sleep at 800 and 1000mg/kg were comparable to
that of diazepam at 3mg/kg. The highest prolongation of
sleep produced by the methanolic extract was comparable
to that of diazepam (3mg/kg). Only the highest dose tested
for ME signiﬁcantly increased from 45 ± 2 to 112 ± 3min;
the duration of hypnos is induced by thiopental (Table 3).
However, the aqueous extract of Lavandula oﬃcinalis at the
doses of 800 and 1000mg/kg, p.o., produced no hypnotic
activitysigniﬁcantonthecentralnervoussystemconﬁrming,
thus, the hypnotic action of lavender methanolic extract at
high doses by oral pathway (Table 3).
4. Discussion
In aromatherapy, the methanolic and aqueous extracts of
Lavandula oﬃcinalis are believed to possess anticonvulsive,
sedative, hypnosis, and antidepressive eﬀectsand to be useful
for treating nervous breakdown, nervous tension, depres-
sion, and insomnia [23–25]. In this paper, we observed the
sedative and hypnotic properties of methanolic and aqueous
extract from Lavandula oﬃcinalis L. in mice. Therefore,
in order to study the comprehensive eﬀect of our drugs,
the following targets were observed: reestablishment time,
number of head dips, and loss of initiative and curiosity in
mice.
Diazepam is central nervous system depressant used
in the management of sleep disorders such as insomnia;
these compounds have a binding site on GABA receptor
type-A ionophore complex (GABAA)[ 4, 5]. It decreases
activity, moderates excitement, and calms the recipient.
Substances like diazepam (which has been chosen as the
standard reference drug in this study) reduce onset of and
increase duration of barbiturate-induced sleep and reduce
exploratoryactivitypossessingpotentialsassedative[21,26].
Lavender extract increased the time of reestablishment by
mice in the traction test (Table 1), after oral administration
of200,400,and600mg/kgdosages,producingsedativeeﬀect
similar to that observed with 3mg/kg diazepam. Diazepam
is a very well-known anxiolytic benzodiazepine (BDS) which
produces not only anxiolytic-like eﬀect but also important
sedative action. In this respect, lavender extract produced4 Advances in Pharmacological Sciences
Table 1: Sedative action of Lavandula oﬃcinalis methanolic extract. p.o. means oral route; i.p. means intraperitoneal route; n means number
of mice per group; sec means seconds; ME: mean methanolic extract; DZP means diazepam. Data are expressed as mean ± SD; P<0.001
versus the control group.
Test Control
Diazepam i.p. Methanolic extract of Lavandula oﬃcinalis in mg/kg p.o.
DZP
(3mg/kg)
ME
(100mg/kg)
ME
(200mg/kg)
ME
(400mg/kg)
ME
(600mg/kg)
Traction test Re-establishment
time
0.09sec ± 0.0 10sec ± 0.3 0.08sec ± 0.5 5sec ± 0.5∗ 18sec ± 0.5∗ 27sec ± 1∗
n = 5 n = 5 n = 5 n = 5 n = 5 n = 5
Fireplace test Time to go back the
tube in seconds
7sec± 0.5 >2min sec ± 0.5 30sec ± 1∗ 0.58sec ± 1∗ >2min ∗
n = 5 n = 5 n = 5 n = 5 n = 5 n = 5
Hole-board test Explored holes during
5m i n u t e s
10 ±10 .0 ±0.08 ±0.12 ±0.0∗ 1 ±0.0∗ 0.0 ± 0.0∗
n = 5 n = 5 n = 5 n = 5 n = 5 n = 5
Table 2: Sedative eﬀect of aqueous extract of Lavandula oﬃcinalis. p.o. means oral route; i.p. means intraperitoneal route; n means number
of mice per group; sec means seconds; AE means aqueous extract; DZP means diazepam. Data are expressed as mean ± SD; P<0.001 versus
the control group.
Test Control
Diazepam i.p. Aqueous extract of Lavandula oﬃcinalis p.o.
DZP
(3mg/kg)
AE
(100mg/kg)
AE
(200mg/kg)
AE
(400mg/kg)
Traction test Re-establishment
time
0.09sec ± 0.0 10sec ± 0.3 2sec ± 0.3 12sec ± 0.5∗ 30sec ± 1∗
n = 5 n = 5 n = 5 n = 4 n = 5
Fireplace test Time to go back the
tube in seconds
7sec± 0.5 >2min 12sec ± 0.1 45sec ± 1∗ >2min ∗
n = 5 n = 5 n = 5 n = 5 n = 4
Hole-board test Explored holes during
5m i n u t e s
10 ±10 .0 ±0.06 ±0.21 ±0.0∗ 0.0 ± 0.0∗
n = 5 n = 5 n = 5 n = 4 n = 4
Table 3: Eﬀect of the methanolic extract of Lavandula oﬃcinalis
on the onset and duration of sleep in thiopental-treated mice. Mice
received thiopental (60mg/kg, i.p.) 30min after the pretreatment
of methanolic extract (800 and 1000mg/kg, p.o.) and diazepam
(3mg/kg, i.p.). i.p. means intraperitoneal route; p.o. means oral
route; (n = 5) means number of mice per group; ME means
methanolic extract; D ZP means diazepam. Data are expressed as
mean ± SD; P<0.001 versus the control group.
Group Dose (mg/kg) Sleep latency
(min)
Sleeping time
(min)
Normal 60 8 ±13 6 ±3
DZP 3 6 ± 1∗ 75 ±3∗
ME 800 12 ±0.5∗ 45 ±2∗
ME 1000 6 ± 1∗ 112 ±3∗
a dose-dependent reduction in the number of head dips in
the hole-board test similar and/or greater than diazepam
(Tables 1 and 2). It is generally believed that locomotor
activity results from brain activation, which is manifested as
an excitation of central neurons involving diﬀerent neuro-
chemicalmechanismandanincreaseincerebralmetabolism.
It is possible that the sedative activity of methanolic and
aqueous extract of Lavandula oﬃcinalis is mediated by
GABAergic pathway, since GABAergic transmission can
produce profound sedation in mice [27]. The inhibitory
action of GABA consists in the opening of chloride channels
to allow hyperpolarizing the membrane, leading to CNS
depression and resulting in sedative and hypnosis activity.
Glutamate and GABA are quantitatively the most important
excitatory and inhibitory neurotransmitters, respectively, in
the mammalian brain [28]. Thus, receptors for these two
neurotransmitters are regarded as important targets for
psychotropic drugs. In the test of thiopental-induced sleep
in mice, the potentiated eﬀect of lavender extract in mice
was represented. It not only prolonged the sleeping time
but also decreased the latency of falling asleep and increases
the rat of sleep onset. The lavender extract has produced
hypnosis at high doses’ that is, 800 and 1000mg/kg. Since
the eﬀect of thiopental on the CNS involves the activa-
tion of the inhibition GABAergic system [29, 30], this
ﬁnding suggests that some constituents in lavender extract
produce facilitation of this inhibitory system (Table 3).
Phytochemical studies have identiﬁed active components in
this plant such as coumarin, chalcones, ﬂavanones, ﬂavones,
ﬂavonols, quercetin, and kaempferol derivatives, suggesting
that they are the main responsible for sedative and hypnotic
activities [4, 6, 31]. Further chemical and pharmacological
analysis of the extract will be conducted to isolate and
characterize the active principles responsible for the sedative
and hypnotic eﬀect. In conclusion, p.o. administration of
methanolic and aqueous extract of Lavandula oﬃcinalis
induces similar sedative eﬀects, supporting its use in folk
medicine. Given that the LD50 value for these extracts was
beyond 5000mg/kg for oral administration, as determinedAdvances in Pharmacological Sciences 5
by Litchﬁeld and Wilcoxon [12]; our results suggest a remote
risk of acute toxicity and good tolerance of these extracts in
traditional medicine. To sum up, this work represents that
the methanolic and aqueous extracts of Lavandula oﬃcinalis
have obvious sedative and hypnotic activity; these data
provide pharmacological basis for its therapeutic eﬃcacy on
insomnia.
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